Cardio Diagnostics Holdings, Inc. has announced a significant expansion of its provider network, adding 15 new medical organizations from various regions across the United States. This...
Spero Therapeutics, Inc. and GSK plc have announced promising results from the pivotal Phase 3 PIVOT-PO trial for **tebipenem HBr**, an investigational oral antibiotic aimed at...
SpringWorks Therapeutics, Inc. has published new long-term efficacy and safety data from the Phase 3 DeFi trial of OGSIVEO® (nirogacestat). This oral gamma secretase inhibitor is...
Moderna, Inc. has announced promising early results from its investigational cancer therapy, mRNA-4359. This data will be presented at the 2025 European Society for Medical Oncology...
The recent “Trenton Plates, The World Takes” event, organized by Cross Community, Inc. and Rise Against Hunger, saw a significant contribution from students at Christina Seix...
Penumbra, Inc., a leading company in thrombectomy technology, announced it will host an investor event on October 26, 2025, during the 2025 Transcatheter Cardiovascular Therapeutics (TCT)...
Students from Groveton High School’s cosmetology program recently embarked on an educational trip to the Farouk USA Headquarters in Houston. Departing at 7 a.m., the students...
Healthcare Services Group, Inc. (NASDAQ:HCSG) has garnered a consensus rating of “Moderate Buy” from six brokerages currently covering the company, according to Marketbeat.com. This rating reflects...
The search for extraterrestrial intelligence (SETI) is undergoing a significant transformation, as proposed in John Gertz’s new book, *Reinventing SETI: New Directions in the Search for...
Elon Musk, the CEO of Tesla, Inc., has confirmed that the company is developing a wheelchair-accessible version of its Robotaxi service. This announcement comes in response...
